Page last updated: 2024-11-02

pd 98059 and Renal Insufficiency, Chronic

pd 98059 has been researched along with Renal Insufficiency, Chronic in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sun, S1
Ning, X1
Zhai, Y1
Du, R1
Lu, Y1
He, L1
Li, R1
Wu, W1
Sun, W1
Wang, H1

Other Studies

1 other study available for pd 98059 and Renal Insufficiency, Chronic

ArticleYear
Egr-1 mediates chronic hypoxia-induced renal interstitial fibrosis via the PKC/ERK pathway.
    American journal of nephrology, 2014, Volume: 39, Issue:5

    Topics: Animals; Cadherins; Calcium-Binding Proteins; Cell Hypoxia; Cells, Cultured; Early Growth Response P

2014